Literature DB >> 7553659

The role of ICAM expression in immunity and disease.

D L Simmons1.   

Abstract

The ICAM family consists of three members. All are ligands for LFA1, and ICAM1 can also bind Mac1. However, the complete repertoire of other ligands has not yet been defined. The ICAMs are not functionally redundant, since they have quite distinct expression profiles and can bind LFA1 differentially. ICAM3 is constitutively and abundantly expressed by all leucocytes, whereas ICAM1 and ICAM2 are expressed at very low levels. ICAM1 is rapidly upregulated by inflammatory cytokines. A current working model for the interplay of the ICAMs is that ICAM3 is the major ligand for LFA1 in the initiation of immune responses and that ICAM1 takes over after these early stages. ICAM3 not only functions as an adhesion molecule, but also is clearly emerging as a potent signalling molecule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553659

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  11 in total

1.  Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1.

Authors:  K L Fisher; J Lu; L Riddle; K J Kim; L G Presta; S C Bodary
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

Review 2.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.

Authors:  M D'Angelica; C Tung; P Allen; M Halterman; K Delman; T Delohery; D Klimstra; M Brownlee; H Federoff; Y Fong
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

4.  Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion.

Authors:  G T Huang; L Eckmann; T C Savidge; M F Kagnoff
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

5.  Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cells.

Authors:  Giuseppina Frasca; Venera Cardile; Carmelo Puglia; Claudia Bonina; Francesco Bonina
Journal:  Clin Exp Gastroenterol       Date:  2012-05-08

6.  Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms.

Authors:  David F Stroncek; Christopher Basil; Dirk Nagorsen; Sara Deola; Eleonora Aricó; Kina Smith; Ena Wang; Francesco M Marincola; Monica C Panelli
Journal:  J Transl Med       Date:  2005-06-13       Impact factor: 5.531

7.  The effects of arginine glutamate, a promising excipient for protein formulation, on cell viability: Comparisons with NaCl.

Authors:  Priscilla Kheddo; Alexander P Golovanov; Kieran T Mellody; Shahid Uddin; Christopher F van der Walle; Rebecca J Dearman
Journal:  Toxicol In Vitro       Date:  2016-02-10       Impact factor: 3.500

8.  Infection of human intestinal epithelial cells by invasive bacteria activates NF-κB and increases ICAM-1 expression through NOD1.

Authors:  Woon Geon Shin; Bum Joon Park; Sung Joong Lee; Jae Gyu Kim
Journal:  Korean J Intern Med       Date:  2017-01-16       Impact factor: 2.884

9.  Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.

Authors:  Dalel Azzazene; Hamda Al Thawadi; Halema Al Farsi; Samaher Besbes; Caroline Geyl; Shahsoltan Mirshahi; Julia Pardo; Anne Marie Faussat; Soria Jeannette; Amu Therwath; Eric Pujade-Lauraine; Massoud Mirshahi
Journal:  Int J Oncol       Date:  2013-07-18       Impact factor: 5.650

10.  E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.

Authors:  Zijia Ren; Wenyao Kang; Lihua Wang; Baoliang Sun; Jiajia Ma; Chaogu Zheng; Jie Sun; Zhigang Tian; Xiaoyi Yang; Weihua Xiao
Journal:  Mol Cancer       Date:  2014-04-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.